Chemokines and chemokine receptors as therapeutic targets in lupus nephritis

被引:44
作者
Vielhauer, Volker [1 ]
Anders, Hans-Joachim [1 ]
Schloendorff, Detlef [1 ]
机构
[1] Klinikum Univ Munchen, Med Poliklin Innenstadt, Munich, Germany
关键词
chemokine; chemokine receptors; systemic lupus erythematosus; MRL/lpr mouse; leukocyte recruitment; kidney; receptor antagonist; polymorphisms;
D O I
10.1016/j.semnephrol.2006.09.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recruitment of leukocytes is a characteristic feature of tissue injury in systemic lupus erythematosus, including lupus nephritis. Locally secreted chemokines and their receptors are important mediators of leukocyte recruitment to the specific sites of immune complex injury, and contribute to renal inflammatory disease in the initiation and progression phase. Therefore, chemokines and chemokine receptors represent potential therapeutic targets in lupus nephritis. In this review we summarize available experimental and human data supporting their functional role in lupus nephritis. Moreover, interventional studies with chemokine and chemokine receptor antagonists that show the therapeutic potential of chemokine antagonists in experimental models of lupus nephritis and potentially in human renal disease are discussed. © 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 97
页数:17
相关论文
共 103 条
[21]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621
[22]   In situ analysis of C-C chemokine mRNA in human glomerulonephritis [J].
Cockwell, P ;
Howie, AJ ;
Adu, D ;
Savage, COS .
KIDNEY INTERNATIONAL, 1998, 54 (03) :827-836
[23]   Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/1pr lupus-prone mice [J].
de Lema, GP ;
Maier, H ;
Franz, TJ ;
Escribese, M ;
Chilla, S ;
Segerer, S ;
Camarasa, N ;
Schmid, H ;
Banas, B ;
Kalaydjiev, S ;
Busch, DH ;
Pfeffer, K ;
Mampaso, F ;
Schlöndorff, D ;
Luckow, B .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12) :3592-3601
[24]  
De Lema GP, 2001, J AM SOC NEPHROL, V12, P1369, DOI 10.1681/ASN.V1271369
[25]   Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction [J].
Eis, V ;
Luckow, B ;
Vielhauer, V ;
Siveke, JT ;
Linde, Y ;
Segerer, S ;
de Lema, GP ;
Cohen, CD ;
Kretzler, M ;
Mack, M ;
Horuk, R ;
Murphy, PM ;
Gao, JL ;
Hudkins, KL ;
Alpers, CE ;
Gröne, HJ ;
Schlöndorff, D ;
Anders, HJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :337-347
[26]   Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus [J].
Eriksson, C ;
Eneslätt, K ;
Ivanoff, J ;
Rantapää-Dahlqvist, S ;
Sundqvist, KG .
LUPUS, 2003, 12 (10) :766-774
[27]   INTERLEUKIN-6 PROMOTES MURINE LUPUS IN NZB/NZW F1-MICE [J].
FINCK, BK ;
CHAN, B ;
WOFSY, D .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :585-591
[28]   CC chemokine receptor 5 and renal-transplant survival [J].
Fischereder, M ;
Luckow, B ;
Hocher, B ;
Wüthrich, RP ;
Rothenpieler, U ;
Schneeberger, H ;
Panzer, U ;
Stahl, RAK ;
Hauser, IA ;
Budde, K ;
Neumayer, HH ;
Krämer, BK ;
Land, W ;
Schlöndorff, D .
LANCET, 2001, 357 (9270) :1758-1761
[29]   Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow [J].
Fong, AM ;
Robinson, LA ;
Steeber, DA ;
Tedder, TF ;
Yoshie, O ;
Imai, T ;
Patel, DD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1413-1419
[30]   Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases [J].
Furuichi, K ;
Wada, T ;
Sakai, N ;
Iwata, Y ;
Yoshimoto, K ;
Shimizu, M ;
Kobayashi, K ;
Takasawa, K ;
Kida, H ;
Takeda, S ;
Mukaida, N ;
Matsushima, K ;
Yokoyama, H .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (04) :291-299